series-a
Stage
2018
Founded
2
Investors
About
RheaVita develops and commercializes continuous freeze-drying technology for biopharmaceutical products, enabling faster process development, enhanced flexibility, and consistent product quality compared to traditional batch methods.
Explore RheaVita's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.